BGMS Prakiraan wutah bathi resik saben saham kanggo taun ngarep cyclacel.com

Can the reputation of Bio Green Med Solution Inc (BGMS) in precision oncology drive revenue growth? The EPS growth prospects for the next fiscal year provide the answer, where 0.00 captures the current value of the indicator. The business model relies on contract manufacturing and external clinical trials, while the company maintains a strong staff of translational medicine experts.

BGMS: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Bio Green Med Solution Inc. 13.09.2025 - 15.11.2026

Rincian metrik keuangan lan pasar Bio Green Med Solution (BGMS)

- rega saham lan konsensus proyeksi valuasi:

Rega saham Cyclacel|BGMS - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar Cyclacel Pharmaceuticals|BGMS - Nilai Dipunlarasaken Utang lan Kas

- rincian nilai buku perusahaan:

Nilai Buku saben Saham Bio Green Med Solution|BGMS - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku cyclacel.com|BGMS - Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas Bio Green Med Solution Inc|BGMS - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal cyclacel.com|BGMS - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Cyclacel|BGMS - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Bio Green Med Solution|Indikator likuiditas cepet cyclacel.com

- informasi bathi lan kelipatan valuasi:

BGMS - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Bio Green Med Solution Inc|BGMS - Nilai perusahaan marang bathi resik|Pangali Forward P/E Cyclacel|BGMS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cyclacel Pharmaceuticals|BGMS - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Bio Green Med Solution|BGMS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cyclacel.com|BGMS - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Bio Green Med Solution Inc

- data dodolan lan asil:

BGMS - Total pendapatan perusahaan|Prakiraan volume dodolan Bio Green Med Solution Inc|BGMS - Rasio rega marang pendapatan|Multiplikator Forward P/S Cyclacel

Analisis fundamental perusahaan:Bio Green Med Solution, BGMS

This indicator measures the expected percentage change in earnings per share, reflecting the analysts' consensus forecast regarding future business profitability. In the context of next year's earnings growth forecast, the ability of Bio Green Med Solution Inc. (BGMS) to raise capital to complete oncology research is critical given the current liquidity shortage. The trend of this metric determines the company's investment attractiveness amid the extreme operational risks of the biotech sector.

Perusahaan pesaing

GMAB (Genmab Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep exelixis.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvalent (NUVL)|KYMR (Kymera) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IDYA (IDEAYA Biosciences Inc)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Enliven Pharma|ORIC Pharmaceuticals Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|TYRA: Proyeksi tambahing bathi saben saham ing taun ngarep|VSTM (verastem.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Monte Rosa Tx GLUE|Prakiraan wutah bathi kanggo taun ngarep CGEM|Immuneering - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|C4 Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BDTX|RPTX: Prakiraan wutah bathi saben saham kanggo taun ngarep|PMV Pharma - Proyeksi tambahing bathi saben saham ing taun ngarep|KPTI: Prakiraan wutah bathi kanggo taun ngarep|Propanc Biopharma Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep aileronrx.com ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks Therapeutics, Inc)